Table 2.
AgeCoDe cohort patient demographics
| Controls | AD Converters | |
|---|---|---|
| Baseline (T1) | ||
| N | 42 | 54 |
| Age at baseline | 81.00 ± 3.11 | 82.31 ± 3.55 |
| Gender (male/female) | 10/32 | 17/37 |
| IDO2 (cg11251498) (%) | 72.53 ± 5.36 | 75.59 ± 3.71 |
| Follow-up (T2) | ||
| N | 42 | 41 |
| Age at baseline | 81.00 ± 3.11 | 82.01 ± 3.51 |
| Gender (male/female) | 10/32 | 13/28 |
| IDO2 (cg11251498) (%) | 73.07 ± 4.91 | 75.25 ± 4.96 |
Overview of patient characteristics in the AgeCoDe cohort used in this study. Data are presented in n or mean ± SD. Patients were age- and gender-matched. Blood was collected at baseline and follow-up (average 4.5 years). All patients were controls at baseline and the patients were followed-up over time